• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/61

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

61 Cards in this Set

  • Front
  • Back
form of H bonds btwn ssRNA/DNA that are comple
n acid hybridization
btwn 2 polynucl chains which have compl bases
principle: at incr temp, dsDNA will denature > ssDNA, whn decr emp, strands anneal due to bp
intermolecular hybridiz
ssRNA/DNA oligonucl labeled with a reporter chem
will hypridize to target n.a. on the basis of bp
probe
DNA/RNA is immobilized on inert support so that self annealing is prevented
bound seq are available for hybrid with added probe
use filter paper (mc)
solid support hybrid
typer of solid support hybrid
S blot
Dot/slot blot
N blot
procedure for transf denatured DNA form an ag. gel to a solid support filter where it can be hybridized with a compl n.a. probe
DNA sep by size so that spec frags can be identified
DNA only
S blot
S blot commonly used to
ident spec seq of DNA in which the frags are sep by electro> a memb and ident with probe
detects restric frags
to screen DNA and cDNA libraries
to study gene expr with RNA
sep RNA Pattern > nylon memb
hybridize with 1 probe only and need separate blot for each probe tested
N blot
for multiple gene expr at once
thousands of probes on slide/memb
target is cDNA/mRNA
fluor labeled probe/target
monitors activity of genes by mRNA hybridiz
Micro array
DNA/RNA bound directly to solid filter
no size sep
for mult samples and quantity
dot/slot blot
id spec translocation breaks, chrom del, and gene amp
for solid tumor study
FISH
target n.a. is ampl
PCR
NASBA
TMA
SDA
signal is ampl
HC2
bDNA
probe is ample
bDNA
ampl DNA
thermal cycling
req: target, primers, Taq, buffer, dNTP
PCR
most sensitive for mRNA
starts with RT, mRNA> cDNA
RT PCR
simul ampl and quant target DNA
Taq man probe= reporter
Real TIme PCR
2 or more mRNA targets at once
Multiplex PCR
to determine order of nucl bases of DNA
Sanger method and maxam gilbert method
DNA seq
polymer chain is term with ddNTPs labeled with diff colors, detected by laser
Sanger method
DNA seq
detects spec proteins in sample
uses SDS PAGE to sep denatured proteins by length
uses 2ndary ab with color/chemil enzyme
for confirm of HIV, Mad cow, lyme disease
W blot
ideal candidates for blood genotyping
Sickle cell
Thall
H anemia
lekemia
pst transf/ pos DAT
incr incidince ag for ID
acceptable samples for genotyping
EDTA blood
cheeck swab- babies and aplastic pts
leukored filters
ideal donors for genotyping
based on dempgraphic area
Blacks for sickle cell pts
screen for rares
when to genotype
prior to transf
to obtain extended pheno
post transf ab ID
DAT pos
why genotyping is done in blood bank
can incr donors by genot screening
incr care and TAT for pts
to find more accurate match
fro discrep and rare ab
gold std for mol diag
N.a. ampl
use known n.a. probe labeled with detector to hybrib to another n.a. with bp
rapid, simple, cheap, accurate
req large number of orgs
non ampl N.a. probes
single/few copies of DNA/RNA are ampl by enzyme under direction of primer
rapid, sensitive, accurate
need extra sample prep, false pos
target ampl
target ampl methods
PCR
NASBA
TMA
SDA
for N. gon, C. trach, M. tuber, HBV, HCV, HIV, CMV
isothermal n.a. ampl based of restr enzyme and polym
for N. gon and C. trach
target1
SDA
signal ampl methods
bDNA
HC2
target n.a. seq not repl but ampl signal from probe
FDA abbroved for HIV and HCV
bDNA
signal ampl after hybrid of target DNA with RNA probe
incr sensitivity
FDA cleared for HPV
HC2
size of entire plasmid.chrom is determined
for genotyping or genetic fingerprint
gold std for patho orgs
PFGE/ DNA fingerprint
direct seq is determined, most accurate
for HepC
N.a. seq
Lim of N.a. ampl
expensive
needed trained techs
contam is easy
rigid QC
need confirm test
DNA is pos, org is absent
can be after antimicrobial therapy (C. trach and B. pert), gene present but not expressed (B. pert), gene present but unable to distiguish from normal flora ( S. pneumo)
Clinical false pos, good
from contam
cross reactivity
Analytical false pos, bad
can be caused by Norovirus, org rapidly cleared, DNA lost during processing, ampl inhibition
False neg
for detecting or correcting defects by estab limits of acceptable performance
QC
for continuing monitoring and improving the reliability, efficiency, and clinical value of lab tests
to decr and prevent errors
CLIA 88, CLSI, ACMG, CAP
QA
QA can be done
in pre analyt, analyt, and post analyt of specimen processing
to prevent contam/carry over
good lab practice
sep pre and pst ampl
PPE
one way work flow
poor collection or wrong source
False neg, good
poor PCR design, inhib PCR, PCR error
False neg, bad
techs for Fragile X
RFLP
S. blot
PCR with RE
methylation
techs for CF
targeted/scanning mutation analysis with PCR
panel sensitivity
CF
CFTR mutation, F508 del is m.c.
Fragile X
trinucl repeat expansions of CGG on FMR-1 gene of X
mc form of inherited mental retardation
more Males
Polymorphism
germ line changes
in 1% of popl
RFLP
VNTR
STR
SNP
mini satellite repeats
for DNA fingerprinting
VNTR
micro satellite repeats of CA, highly suscep to mutation when DNA repair mech lost
use PCR and tumor testing
STR
single nucl variations
detect with PCR or DNA Chip
SNP
for BRAF/KRAS
sequencing, RT-PCR, hybridiz (Dot blot)
for HER2
FISH
for HPV
HC2, cervical swab, PCR/tumor spec
causes 67% of melanoma
v600E= 90% of mutations
caused by GAG mutation
BRAF
mutations prevent GTP hydrolysis= always on > incr repl
most mutations in codons 12,13,61 on chrom 12
G>T = Val instead of Gly > abn growth
KRAS
predisp of BRAC1, 2 genes
predict with HER2 ampl target
FISH- fluor prob on tissue
breast cancer
all contain HPV DNA
HPV 16, 18, 31= 95%
use HC2, signal ampl
detects but doesnt distinguish
Cervical cancer